KR880003624A - 신규의 시네르지스트 약제학적 조성물과 이의 용도 및 제조방법 - Google Patents

신규의 시네르지스트 약제학적 조성물과 이의 용도 및 제조방법 Download PDF

Info

Publication number
KR880003624A
KR880003624A KR870010125A KR870010125A KR880003624A KR 880003624 A KR880003624 A KR 880003624A KR 870010125 A KR870010125 A KR 870010125A KR 870010125 A KR870010125 A KR 870010125A KR 880003624 A KR880003624 A KR 880003624A
Authority
KR
South Korea
Prior art keywords
thromboxane
pharmaceutical composition
antagonist
pharmaceutical compositions
sinerzist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR870010125A
Other languages
English (en)
Korean (ko)
Inventor
하르만 발테르
니클 요셉
Original Assignee
디에테르 라우디엔, 게르하드 휴버
닥터 칼 토매 게엠바하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디에테르 라우디엔, 게르하드 휴버, 닥터 칼 토매 게엠바하 filed Critical 디에테르 라우디엔, 게르하드 휴버
Publication of KR880003624A publication Critical patent/KR880003624A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR870010125A 1986-09-13 1987-09-12 신규의 시네르지스트 약제학적 조성물과 이의 용도 및 제조방법 Withdrawn KR880003624A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863631294 DE3631294A1 (de) 1986-09-13 1986-09-13 Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem thromboxan-a(pfeil abwaerts)2(pfeil abwaerts)-antagonisten und deren verwendung bzw. herstellung
DEP3631294.0 1986-09-13

Publications (1)

Publication Number Publication Date
KR880003624A true KR880003624A (ko) 1988-05-28

Family

ID=6309586

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870010125A Withdrawn KR880003624A (ko) 1986-09-13 1987-09-12 신규의 시네르지스트 약제학적 조성물과 이의 용도 및 제조방법

Country Status (12)

Country Link
EP (1) EP0260527B1 (cg-RX-API-DMAC10.html)
JP (1) JPS6379838A (cg-RX-API-DMAC10.html)
KR (1) KR880003624A (cg-RX-API-DMAC10.html)
AU (1) AU597718B2 (cg-RX-API-DMAC10.html)
DE (2) DE3631294A1 (cg-RX-API-DMAC10.html)
DK (1) DK472487A (cg-RX-API-DMAC10.html)
ES (1) ES2033755T3 (cg-RX-API-DMAC10.html)
GR (1) GR3004969T3 (cg-RX-API-DMAC10.html)
IL (1) IL83872A0 (cg-RX-API-DMAC10.html)
NZ (1) NZ221779A (cg-RX-API-DMAC10.html)
PH (1) PH23553A (cg-RX-API-DMAC10.html)
ZA (1) ZA876806B (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306846A3 (de) * 1987-09-11 1990-05-02 Dr. Karl Thomae GmbH Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
JP2003509478A (ja) 1999-09-21 2003-03-11 エモリー・ユニバーシティ 血小板関連障害を処置する方法および組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291368A (en) * 1979-03-30 1981-09-22 Borg-Warner Corporation Pulse-width modulated inverter system and method
DE3166627D1 (en) * 1980-12-12 1984-11-15 Thomae Gmbh Dr K Pyrimidones, their preparation and medicines containing them
DE3049207A1 (de) * 1980-12-27 1982-07-29 Dr. Karl Thomae Gmbh, 7950 Biberach Neue trisubstituierte pyrimido (5,4-d) pyrimidine, ihre herstellung und ihre verwendung als arzneimittel
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor

Also Published As

Publication number Publication date
EP0260527A3 (en) 1989-08-09
GR3004969T3 (cg-RX-API-DMAC10.html) 1993-04-28
ES2033755T3 (es) 1993-04-01
JPS6379838A (ja) 1988-04-09
PH23553A (en) 1989-08-25
EP0260527A2 (de) 1988-03-23
DE3777926D1 (de) 1992-05-07
DE3631294A1 (de) 1988-03-24
AU7829687A (en) 1988-03-17
DK472487D0 (da) 1987-09-10
AU597718B2 (en) 1990-06-07
EP0260527B1 (de) 1992-04-01
IL83872A0 (en) 1988-02-29
DK472487A (da) 1988-03-14
NZ221779A (en) 1990-03-27
ZA876806B (en) 1989-05-30

Similar Documents

Publication Publication Date Title
AU538424B2 (en) Piperazino phenylindane
KR860004060A (ko) 티에닐 축합 피라졸 유도체의 제조방법
KR890002030A (ko) 메데토 미딘의 d 및 1 에난티오머, 그 분리 방법 및 이를 포함하는 제약학적 조성물
JO1502B1 (en) New pharmacy vehicles
SE8702907D0 (sv) Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
KR850008170A (ko) 피롤로 벤즈 이미다졸의 제조방법과 그들 함유의 약학적 조성물
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
HUT71105A (en) Mercaptoacylamino-substituted benzazepines condensed with heterocycles, process for preparing them and pharmaceutical compositions of enkephalinase and ace inhibitor activity containing said compounds
ES8207169A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
SE8703169L (sv) 1-(4-aminofenyl)-4-metyl-7,8-metylendioxi-3,4-dihydro-5h-2,3-bensodiazepin, syraadditionssalter derav samt forfarande for framstellning av densamma
IL72900A0 (en) Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
FR2699176B1 (fr) Nouveaux composés bicycliques de pyrimidine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
ATE60604T1 (de) 1h-indol-3-yl enthaltende 1,3-dimethyl-1-h-purine-2,6-dione.
GR3000490T3 (en) Selective alpha-adrenergic receptor antagonists
DE3668888D1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
GB1279543A (en) Novel imidazolines, the preparation thereof and compositions containing the same
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
EP0173377A3 (en) Pyrimidone compounds, their preparation and pharmaceutical compositions containing them
NO833529L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alfa-aryl-alfa-pyridylalkansyrederivater
DE3777926D1 (de) Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem tromboxan-a2-antagonisten und deren verwendung bzw. herstellung.
KR940005610A (ko) 신규한 피페리딘 유도체 및 이의 제조방법
IE42230L (en) Pharmaceutical combination preparation
JPS56152418A (en) Hypoglycemic agent
RU97122020A (ru) Производные 1,2,5-оксадиазоло[3,4-d]пиридазин-5,6-диоксида в качестве активаторов растворимой формы гуанилатциклазы и средств для лечения заболеваний сердечно-сосудистой системы и фармацевтические композиции на их основе
JPS5692213A (en) Anticoagulant comprising n2-arylsulfonyl-l-arginine amide or its salt as active ingredient

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19870912

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid